[1]
“Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report”, Reumatismo, vol. 76, no. 2, Jun. 2024, doi: 10.4081/reumatismo.2024.1687.